Chimeric Therapeutics Ltd Sustainability Reports
Chimeric Therapeutics Limited is a clinical-stage cell therapy company focused on the discovery, development, and commercialization of oncology therapies. The company specializes in innovative CAR T cell and NK cell platforms to target and treat blood cancers and solid tumors.
Sector: Professional & technical services
Country: Australia
Exchange: Australian Securities Exchange
FIGI: BBG00YD0SSP1
8 reports from 2020 to 2024
